United States · FDA National Drug Code directory
Flexbumin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0944-0495_14185d93-8688-4431-9f2b-db36e3ef7ec5
- Product NDC
- 0944-0495
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Albumin Human
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20140731
- Source listing expiry
- 20261231
Source-listed ingredients
- ALBUMIN HUMAN — .05 g/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 BAG in 1 CARTON (0944-0495-05) / 250 mL in 1 BAG (0944-0495-06) · 0944-0495-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →